Interesting anyone seen or heard much about this? Looks different as the goal is to regenerate cartilage
Novartis receives FDA fast track designation for LNA043 in osteoarthritis of the knee | Novartis
- Forums
- ASX - By Stock
- Novartis LNA043
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.61%
!
30.5¢

Interesting anyone seen or heard much about this? Looks...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
-0.005(1.61%) |
Mkt cap ! $120.7M |
Open | High | Low | Value | Volume |
30.0¢ | 31.0¢ | 29.5¢ | $313.3K | 1.034M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 257 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 978 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 977 | 0.305 |
5 | 44324 | 0.300 |
3 | 74660 | 0.295 |
3 | 189654 | 0.290 |
6 | 65988 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 978 | 1 |
0.300 | 51 | 1 |
0.310 | 114477 | 2 |
0.315 | 10000 | 1 |
0.320 | 231 | 1 |
Last trade - 15.59pm 05/05/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Director
Ron Miller
Director
Previous Video
Next Video
SPONSORED BY The Market Online